Clinical Trials
All Clinical Trials - Page 44 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02668588Phase 2Completed
Extended-release of Octreotide (LF-PB) for the Treatment of Seroma
Octreotide
- NCT02354768Phase 3Terminated
Evaluation of Lanreotide Efficacity in High Output Stoma: a Multicentric Randomized Study
Lanreotide
- NCT02559206Phase 2Completed
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Linaclotide
- NCT02453711Phase 2Completed
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
Semaglutide
- NCT02637284Phase 1Unknown
PCO-02 - Safety and Pharmacokinetics Trial
BPC-157
- NCT02715336Phase 4Unknown
Efficacy and Safety of Medication Used to Stimulate Ovulation
Gonadorelin
- NCT02503605Phase 4Unknown
Biosimilar Versus Urinary Gonadotropins
Gonadorelin
- NCT02527993Phase 4Completed
Treatment of Hypoglycemia Following Gastric Bypass Surgery
Liraglutide
- NCT02577848N/AUnknown
GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
Liraglutide
- NCT02437825Phase 2Unknown
Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery
Octreotide
- NCT02461589Phase 2Completed
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
Semaglutide
- NCT02381288Phase 2Terminated
Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone
Kisspeptin
- NCT02584231Phase 4Completed
Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population
Desmopressin
- NCT02518191Phase 3Completed
Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity
Gonadorelin
- NCT03119584Phase 4Active Not Recruiting
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
Linaclotide
- NCT02597803Phase 2/Phase 3Completed
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
TB-500
- NCT02542137Phase 2Withdrawn
Abscopal Effect for Metastatic Small Cell Lung Cancer
Thymosin-Alpha-1
- NCT02535988Phase 2Withdrawn
Abscopal Effect for Metastatic Colorectal Cancer
Thymosin-Alpha-1
- NCT06106932N/ACompleted
GnRH-a on Angiogenesis of Endometriosis
Gonadorelin
- NCT02455076Phase 4Completed
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
Exenatide
- NCT02794402Phase 2Completed
Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
Exenatide
- NCT02384122Phase 3Completed
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
Octreotide
- NCT02636387N/ATerminated
Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease
Desmopressin
- NCT02500979Phase 1Completed
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus
Pramlintide
- NCT02427958Phase 4Completed
A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants
Gonadorelin
- NCT02917057N/ACompleted
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
Exenatide
- NCT02690987EARLY_Phase 1Unknown
Gut Hormones in Obesity, Nicotine and Alcohol Dependence
Exenatide
- NCT02518945Phase 3Completed
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
Liraglutide
- NCT02660047Phase 4Completed
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
Liraglutide
- NCT02473809Phase 4Completed
The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
Liraglutide
- NCT02058940Phase 4Completed
Intravenous Exenatide in Patients With Acute Brain Injury
Exenatide
- NCT02541734Phase 1/Phase 2Completed
Effect of Gelofusine on GLP1-receptor Imaging
Exenatide
- NCT02467920Phase 4Completed
Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM
Exenatide
- NCT02640118N/ACompleted
The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects
Lixisenatide
- NCT02668172Phase 4Unknown
Pasireotide LAR and Pegvisomant Study in Acromegaly
Octreotide
- NCT02406690N/ACompleted
Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects
Gonadorelin
- NCT02492763Phase 2Terminated
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Liraglutide
- NCT02420262Phase 3Completed
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT02505334Phase 3Completed
A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
Liraglutide
- NCT02231658Phase 1Terminated
Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
Liraglutide
- NCT03089073N/ATerminated
Study of Minirin Melt® in Adult Patients With Nocturia
Desmopressin
- NCT02160353Phase 2Completed
Neo-adjuvant Abiraterone Prostate Study
Gonadorelin
- NCT02225366Phase 1/Phase 2Completed
Intratumoral Injections of LL37 for Melanoma
Ll-37
- NCT02196831N/ACompleted
Tesamorelin Effects on Liver Fat and Histology in HIV
Tesamorelin
- NCT02440581N/ACompleted
Renal Osteodystrophy: An Individual Management Approach
Teriparatide
- NCT02542501N/ACompleted
Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues
Gonadorelin
- NCT02584582Phase 2/Phase 3Unknown
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
Liraglutide
- NCT02507128N/AUnknown
Effects of Glucagon Like Peptide-1 on No-reflow
Liraglutide
- NCT02909933Phase 4Completed
Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
Liraglutide
- NCT02490176N/AUnknown
Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
Liraglutide